Senate HHS Approps Chair Harkin Looking At FDA Rules On Women In Trials
Executive Summary
The representation of women in clinical trials will be a likely hearing topic for the Senate Appropriations/Labor, HHS & Education Subcommittee under incoming Chairman Harkin (D-Iowa).
You may also be interested in...
Recent Drug Withdrawals Had Greater Health Risks For Women - GAO Report
Eight of 10 prescription drugs withdrawn from the market since Jan. 1, 1997 presented more significant health risks for women than men, a General Accounting Office report finds.
FDA Adverse Event Monitoring "Flaws" Highlighted In GAO Transition Report
Improving the monitoring of drug adverse events is one of FDA's main challenges, a General Accounting Office transition report on HHS indicates.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011